MRI Study to Visualize Protective Effects of Natural Gastrointestinal therapy
A groundbreaking collaboration between the University of Nottingham and Italian healthcare company Aboca is leveraging magnetic resonance imaging (MRI) to gain unprecedented insight into how natural therapies interact with the human digestive system. the feasibility study, announced this week, aims to visually track the protective film created by the neobianacid medical device on the esophagus and stomach lining.
The research represents a significant step toward understanding the mechanisms behind natural remedies and could pave the way for more effective treatments for gastrointestinal ailments. Researchers will utilize MRI technology to observe, in real-time, how NeoBianacid forms a protective barrier in vivo – within a living organism.
NeoBianacid is a medical device formulated with 100% natural and biodegradable substances. Its core component, Poliprotect, is a patented complex derived from plant polysaccharides sourced from Althaea officinalis, Malva sylvestris, and aloe vera.These are combined with minerals like nahcolite and limestone, alongside a flavonoid fraction from Matricaria recutita and Glycyrrhiza glabra.
The study builds upon existing clinical evidence demonstrating NeoBianacid’s efficacy. A trial published in the American Journal of Gastroenterology in July 2023 revealed that NeoBianacid performed comparably to omeprazole (20mg) in alleviating heartburn and epigastric burning in patients without gastroduodenal lesions or erosive esophagitis. This suggests a potential natural alternative for managing common acid-related digestive issues.
“This is the first time that MRI has been used to assess the effect of coating a natural product on the upper gastrointestinal tract and represents an critically important step towards a better understanding of how natural therapies work within the human body,” stated a researcher from the University of Nottingham school of Medicine.
The current MRI study seeks to validate MRI as a non-invasive method for monitoring the formation and persistence of NeoBianacid’s protective layer on the stomach and esophageal mucosa in healthy volunteers. Success in this endeavor could facilitate future investigations into a wider range of natural medical devices and therapies, ultimately enhancing our understanding of their therapeutic potential.
Why: Researchers are conducting this study to gain a deeper understanding of how natural therapies, specifically NeoBianacid, interact with the human digestive system and to validate MRI as a tool for visualizing these interactions. The goal is to move beyond anecdotal evidence and establish a scientific basis for the efficacy of natural remedies.
Who: The study is a collaboration between the University of Nottingham school of Medicine in the UK and Aboca, an Italian healthcare company specializing in natural remedies. Researchers at the University of Nottingham are leading the MRI component, while Aboca developed and provides NeoBianacid. Healthy volunteers are participating in the study.
What: The study involves using MRI technology to visually track the protective film created by NeoBianacid on the esophagus and stomach lining in vivo. NeoBianacid is a medical device composed of natural, biodegradable substances designed to create a physical barrier against acid and irritation. Previous clinical trials have shown NeoBianacid to be as effective as omeprazole in relieving heartburn.
How did it end? The study is currently ongoing as a feasibility study.The researchers aim to validate MRI as a non-invasive method for monitoring the protective layer. The ultimate outcome will determine if MRI can be routinely used to assess the effectiveness of natural gastrointestinal therapies, possibly opening doors for further research and growth in this field. The study’s success will pave the way for investigating a wider range of natural medical devices and therapies.
